These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28620095)

  • 1. Responses to Cytokines and Interferons that Depend upon JAKs and STATs.
    Stark GR; Cheon H; Wang Y
    Cold Spring Harb Perspect Biol; 2018 Jan; 10(1):. PubMed ID: 28620095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inteferons pen the JAK-STAT pathway.
    Schindler C; Plumlee C
    Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
    Cai B; Cai JP; Luo YL; Chen C; Zhang S
    Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn errors of human JAKs and STATs.
    Casanova JL; Holland SM; Notarangelo LD
    Immunity; 2012 Apr; 36(4):515-28. PubMed ID: 22520845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of T cell homeostasis by JAKs and STATs.
    Ross JA; Nagy ZS; Cheng H; Stepkowski SM; Kirken RA
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):231-45. PubMed ID: 17659375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropy and redundancy of STAT proteins in early pregnancy.
    Maj T; Chelmonska-Soyta A
    Reprod Domest Anim; 2007 Aug; 42(4):343-53. PubMed ID: 17635769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT: Why choose a classical or an alternative pathway when you can have both?
    Puigdevall L; Michiels C; Stewardson C; Dumoutier L
    J Cell Mol Med; 2022 Apr; 26(7):1865-1875. PubMed ID: 35238133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFK-STAT pathway: an alternative and important way to malignancies.
    Hayakawa F; Naoe T
    Ann N Y Acad Sci; 2006 Nov; 1086():213-22. PubMed ID: 17185518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex modulation of cell type-specific signaling in response to type I interferons.
    van Boxel-Dezaire AH; Rani MR; Stark GR
    Immunity; 2006 Sep; 25(3):361-72. PubMed ID: 16979568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAKs, STATs and signal transduction in response to the interferons and other cytokines.
    Briscoe J; Guschin D; Rogers NC; Watling D; Müller M; Horn F; Heinrich P; Stark GR; Kerr IM
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):167-71. PubMed ID: 8650263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).
    Pellegrini S; Dusanter-Fourt I
    Eur J Biochem; 1997 Sep; 248(3):615-33. PubMed ID: 9342212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
    Heim MH
    J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How cells respond to interferons revisited: from early history to current complexity.
    Stark GR
    Cytokine Growth Factor Rev; 2007; 18(5-6):419-23. PubMed ID: 17683974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK-STAT signaling: from interferons to cytokines.
    Schindler C; Levy DE; Decker T
    J Biol Chem; 2007 Jul; 282(28):20059-63. PubMed ID: 17502367
    [No Abstract]   [Full Text] [Related]  

  • 15. Jaks and STATs: biological implications.
    Leonard WJ; O'Shea JJ
    Annu Rev Immunol; 1998; 16():293-322. PubMed ID: 9597132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell homeostasis and the JAK-STAT pathway.
    Morales JK; Falanga YT; Depcrynski A; Fernando J; Ryan JJ
    Genes Immun; 2010 Dec; 11(8):599-608. PubMed ID: 20535135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jaks and Stats in signaling by the cytokine receptor superfamily.
    Ihle JN; Kerr IM
    Trends Genet; 1995 Feb; 11(2):69-74. PubMed ID: 7716810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
    Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
    J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
    Reddy EP; Korapati A; Chaturvedi P; Rane S
    Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors.
    Garrido-Trigo A; Salas A
    J Crohns Colitis; 2020 Aug; 14(Supplement_2):S713-S724. PubMed ID: 32083640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.